Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

390 public trials 102 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

NCT00780663

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoma, +7 more
Locations: Birmingham Hematology and Oncology Birmingham, Alabama, United States

Rocky Mountain Cancer Centers Denver, Colorado, United States

Front Range Cancer Specialists Fort Collins, Colorado, United States

Ocala, Florida, United States

View all 13 locations

View Trial Details

Completed

Gastrointestinal Motility in Patients With Neuroendocrine Tumors

NCT00789841

Conditions: Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Neoplasms, +7 more
Locations: Analfysiologisk afsnit, Aarhus University Hospital, Tage Hansensgade, entrance 11A Aarhus, Denmark

View Trial Details

Completed

Pemetrexed in Patients With Advanced Neuroendocrine Tumors

NCT00424723

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Dana-Farber Cancer Center Boston, Massachusetts, United States

View Trial Details

Completed

High Dose Somatostatin Analogues in Neuroendocrine Tumors

NCT00990535

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Digestive System Neoplasms, +24 more
Locations: University Federico II of Naples Naples, Italy

View Trial Details

Completed

5FU and Octreotide Long-acting Release (LAR) for Neuroendocrine Tumors

NCT00953394

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Neuroendocrine, +7 more
Locations: Federico Castiglione Alba, Cuneo, Italy

Davide Perroni Saluzzo, Cuneo, Italy

Benedetta Ferretti San Severino Marche, Macerata, Italy

Sebastiano Bombaci Ivrea, Torino, Italy

View Trial Details

Completed

Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors

NCT00165230

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +4 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Beth Israel Deaconness Medical Center Boston, Massachusetts, United States

View Trial Details

Completed

SPECT/CT in Endocrine and Neuroendocrine Tumors

NCT00230139

Conditions: Endocrine and Neuroendocrine Tumors, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations: Rambam Medical Center Haifa, Israel

View Trial Details

Completed

Treatment With SU11248 in Patients With Neuroendocrine Tumors

NCT00056693

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Birmingham, Alabama, United States

Pfizer Investigational Site Los Angeles, California, United States

Pfizer Investigational Site Los Angeles, California, United States

View Trial Details

Terminated

SwissNET - a Registry for Neuroendocrine Tumours in Switzerland

NCT01039922

Conditions: Adenocarcinoma, Carcinoid Tumor, Carcinoma, +7 more
Locations: Kantonsspital Aarau Aarau, Switzerland

Spitalnetz Bern Aarberg Aarberg, Switzerland

Bezirksspital Affoltern Affoltern am Albis, Switzerland

Kantonsspital Uri, Altdorf Altdorf, Switzerland

View all 55 locations

View Trial Details

Terminated

A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use

NCT03145857

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations: Cross Cancer Institute Edmonton, Alberta, Canada

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions